About Entera Bio Ltd.
https://www.enterabio.comEntera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs.
CEO
Miranda J. Toledano
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
KNOLL CAPITAL MANAGEMENT, LLC
Shares:5.88M
Value:$9.59M
POINT72 ASSET MANAGEMENT, L.P.
Shares:1.18M
Value:$1.92M
MARSHALL WACE, LLP
Shares:627.33K
Value:$1.02M
Summary
Showing Top 3 of 25
About Entera Bio Ltd.
https://www.enterabio.comEntera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $3.25M ▲ | $-3.2M ▼ | 0% | $0.07 ▲ | $-3.19M ▼ |
| Q2-2025 | $0 ▼ | $2.67M ▲ | $-2.66M ▼ | 0% ▲ | $-0.06 ▼ | $-2.66M ▼ |
| Q1-2025 | $42K ▼ | $2.56M ▲ | $-2.57M ▼ | -6.11K% ▼ | $0.06 ▲ | $-2.56M ▼ |
| Q4-2024 | $82K ▲ | $2.34M ▼ | $-2.36M ▲ | -2.88K% ▲ | $-0.06 ▼ | $-2.33M ▲ |
| Q3-2024 | $42K | $3.02M | $-3.02M | -7.19K% | $0.08 | $-3.01M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $8.57M ▼ | $17.41M ▼ | $2.17M ▼ | $15.23M ▼ |
| Q2-2025 | $10.86M ▼ | $19.67M ▼ | $2.41M ▲ | $17.26M ▼ |
| Q1-2025 | $12.57M ▲ | $21.6M ▲ | $2.22M ▲ | $19.38M ▲ |
| Q4-2024 | $8.66M ▲ | $9.39M ▲ | $1.31M ▲ | $8.08M ▲ |
| Q3-2024 | $6.92M | $7.74M | $1.29M | $6.45M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.2M ▼ | $-2.74M ▼ | $-46.47K ▼ | $803.74K ▲ | $-2.27M ▼ | $-2.79M ▼ |
| Q2-2025 | $-2.66M ▼ | $-1.65M ▼ | $-29.18K ▼ | $13.06K ▼ | $-1.7M ▼ | $-1.67M ▼ |
| Q1-2025 | $-2.57M ▼ | $-1.4M ▲ | $-8K ▼ | $13.34M ▲ | $11.91M ▲ | $-1.41M ▲ |
| Q4-2024 | $-2.36M ▲ | $-1.47M ▲ | $-3K ▼ | $3.22M ▲ | $1.75M ▲ | $-1.47M ▲ |
| Q3-2024 | $-3.02M | $-2.15M | $0 | $13K | $-2.14M | $-2.15M |
CEO
Miranda J. Toledano
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
KNOLL CAPITAL MANAGEMENT, LLC
Shares:5.88M
Value:$9.59M
POINT72 ASSET MANAGEMENT, L.P.
Shares:1.18M
Value:$1.92M
MARSHALL WACE, LLP
Shares:627.33K
Value:$1.02M
Summary
Showing Top 3 of 25